Cell Therapy Technologies Market to reach USD 36 billion in 2031, expanding at a CAGR of 10.5%: TMR Report Wilmington, Delaware, United States, June 19, 2023 (GLOBE NEWSWIRE) -- In 2022, the global cell therapy technologies market was estimated to be worth $14.9 billion USD. It is expected to grow at a...

New Research Published in Toxicology in Vitro Provides Insight Into the Hepatotoxicity of DHODH Inhibitors Suggesting ASLAN003 Has the Potential to Be Best-In-Class — New research shows ASLAN003 to have the lowest potential for hepatotoxicity of the compounds tested despite being one of the most potent DHODH inhibitors — Data differentiates ASLAN003 from first...

ASLAN Pharmaceuticals to Develop ASLAN003 as Next Generation DHODH Inhibitor in Autoimmune Conditions --  ASLAN believes ASLAN003 has the potential to be the most potent oral inhibitor of DHODH currently in development for autoimmune disease, more than 30 times more potent at inhibiting the DHODH...